WuXi AppTec
United States
About WuXi AppTec
126 articles about WuXi AppTec
-
WuXi AppTec Plans China IPO
3/28/2017
-
WuXi AppTec Lab Testing Division's Bioanalytical Service Unit Passed FDA Inspection
3/1/2017
-
WuXi AppTec's STA Pharmaceutical To Expand Changzhou Site
2/3/2017
-
WuXi AppTec Release: Company Acquires Biology Focused R&D Service Leader HD Biosciences Co., Ltd
1/19/2017
-
WuXi AppTec Release: Novel Anti-IL-6 Antibody For Rheumatoid Arthritis From WuXi-MedImmune Joint Venture Receives Clinical Trial Permit (CTP) From CFDA
1/18/2017
-
WuXi AppTec Unveils Manufacturing Center For Cutting Edge Cell And Gene Therapies
10/7/2016
-
WuXi AppTec Completes First Phase Of $125 Million Biologics Manufacturing Facility
9/23/2016
-
WuXi AppTec Lab Testing Division And Autogenomics Form Strategic Partnership To Introduce Advanced Molecular Diagnostic Technology To China
9/9/2016
-
WuXi AppTec Gains China Rights To AutoGenomics' Molecular Diagnostic Platform
9/9/2016
-
Ajaz Hussain And WuXi AppTec’s Dr Minzhang Chen Join 12 Strong CPhI Annual Industry Report Experts
9/6/2016
-
WuXi AppTec's STA Subsidiary Passed Third U.S. FDA Inspection
8/15/2016
-
WuXi AppTec's Subsidiary to Open Up Shop in San Diego
8/9/2016
-
WuXi AppTec's Research Service Division Collaborates With Pelago Bioscience To Provide CETSA Based Target Engagement Assays
8/1/2016
-
WuXi AppTec Adopts Reaxys And Reaxys Medicinal Chemistry To Support Research And Expansion Ambitions
6/13/2016
-
WuXi AppTec And Huawei Launch China Big Data Precision Medicine Project
5/26/2016
-
WuXi AppTec's Pharmaceutical Development Service And Analytical Service Passes European Medicines Agency Inspection
5/12/2016
-
At WuXi AppTec, Partnerships Expedite Drug Development And Approvals: Interview With Dr. Hua Mu
5/9/2016
-
WuXi AppTec Acquires CRELUX GmbH
4/15/2016
-
WuXi AppTec Lab Testing Division's Analytical And Stability Testing Facilities Passed FDA Inspection
4/11/2016
-
Week In Review: WuXi AppTec And Juno Form China Immuno-Oncology JV
4/11/2016